Patients with a high probability of HFpEF may experience greater benefits from atrial fibrillation ablation than those with a ...

PFA is a newer Afib ablation modality touted as reducing the risk of damaging nearby collateral structures, compared with ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Catheter Ablation Devices for Atrial Fibrillation Market 2035, Driven by advanced devices, better clinical outcomes, and rising regulatory approvals.

Atrial fibrillation is frequently treated with ablation ... When these AI-created patterns were applied to 3D heart models ...

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of ...

With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing ...

Field Medical Inc., a pioneer in cardiac pulsed field ablation (PFA) technology, today announced the successful closing of ...

Researchers at UC San Diego Health have developed an AI-powered, non-invasive mapping system to accurately locate arrhythmia ...

Jackson-Madison County General Hospital now offers a new therapy to treat patients with advanced atrial fibrillation, who ...

Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced ...